Literature DB >> 18558358

What is the contents of the magic draft IVIg?

Jean-François Seite1, Yehuda Shoenfeld, Pierre Youinou, Sophie Hillion.   

Abstract

Intravenous immunoglobulins (IVIg) consist of IgG concentrated from pooled plasma of numerous donors. Their contents is variable, depending in part on the method of preparation. Natural antibodies and natural autoantibodies are prominent in these preparations and their function. Among these, are the idiotype (Id)/anti-Id dimers. Attention has recently been paid to Fc-gamma receptors and sialylation of the IgG from IVIg.

Mesh:

Substances:

Year:  2008        PMID: 18558358     DOI: 10.1016/j.autrev.2008.04.012

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  51 in total

1.  Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain-Barré syndrome patients.

Authors:  Mohan S Maddur; Magalie Rabin; Pushpa Hegde; Francis Bolgert; Moneger Guy; Jean-Michel Vallat; Laurent Magy; Jagadeesh Bayry; Srini V Kaveri
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  Intravenous immunoglobulin expands regulatory T cells in autoimmune rheumatic disease.

Authors:  Jagadeesh Bayry; Luc Mouthon; Srini V Kaveri
Journal:  J Rheumatol       Date:  2012-02       Impact factor: 4.666

Review 3.  Guillain-Barré syndrome--a classical autoimmune disease triggered by infection or vaccination.

Authors:  Eitan Israeli; Nancy Agmon-Levin; Miri Blank; Joab Chapman; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 4.  Polyvalent immunoglobulins: challenges and perspectives.

Authors:  Isabella Quinti; Serelina Coluzzi; Federica Pulvirenti; Alessandro Prezzo; Gabriella Girelli
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

5.  Mechanisms of action of immune globulin.

Authors:  E Fernández-Cruz; D Alecsandru; S Sánchez Ramón; S S Ramón
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

6.  Autoantibodies to the delta-opioid receptor function as opioid agonists and display immunomodulatory activity.

Authors:  Parvathi Ranganathan; Hao Chen; Miranda K Adelman; Samuel F Schluter
Journal:  J Neuroimmunol       Date:  2009-10-30       Impact factor: 3.478

7.  Recurrent myelitis in common variable immunodeficiency successfully managed with high-dose subcutaneous immunoglobulin.

Authors:  Maria Giovanna Danieli; Lucia Pettinari; Lucia Marinangeli; Francesco Logullo
Journal:  BMJ Case Rep       Date:  2012-08-08

8.  sHLA-I Contamination, a novel mechanism to explain ex vivo/in vitro modulation of IL-10 synthesis and release in CD8(+) T lymphocytes and in neutrophils following intravenous immunoglobulin infusion.

Authors:  Massimo Ghio; Paola Contini; Maurizio Setti; Gianluca Ubezio; Clemente Mazzei; Gino Tripodi
Journal:  J Clin Immunol       Date:  2010-02-02       Impact factor: 8.317

Review 9.  Intravenous immunoglobulins--understanding properties and mechanisms.

Authors:  A Durandy; S V Kaveri; T W Kuijpers; M Basta; S Miescher; J V Ravetch; R Rieben
Journal:  Clin Exp Immunol       Date:  2009-12       Impact factor: 4.330

Review 10.  The advantage of specific intravenous immunoglobulin (sIVIG) on regular IVIG: experience of the last decade.

Authors:  Nina Svetlicky; Oscar-Danilo Ortega-Hernandez; Luc Mouthon; Loic Guillevin; Hans-Jurgen Thiesen; Arie Altman; Martine Szyper Kravitz; Miri Blank; Yehuda Shoenfeld
Journal:  J Clin Immunol       Date:  2012-12-11       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.